141 related articles for article (PubMed ID: 17294608)
21. No major association of ApoE genotype with disease characteristics and MRI findings in multiple sclerosis.
Zwemmer JN; van Veen T; van Winsen L; van Kamp GJ; Barkhof F; Polman CH; Uitdehaag BM
Mult Scler; 2004 Jun; 10(3):272-7. PubMed ID: 15222690
[TBL] [Abstract][Full Text] [Related]
22. Association of APOE polymorphisms with disease severity in MS is limited to women.
Kantarci OH; Hebrink DD; Achenbach SJ; Pittock SJ; Altintas A; Schaefer-Klein JL; Atkinson EJ; De Andrade M; McMurray CT; Rodriguez M; Weinshenker BG
Neurology; 2004 Mar; 62(5):811-4. PubMed ID: 15007140
[TBL] [Abstract][Full Text] [Related]
23. Association between apolipoprotein E gene polymorphism and the risk of multiple sclerosis: a meta-analysis of 6977 subjects.
Yin YW; Zhang YD; Wang JZ; Li BH; Yang QW; Fang CQ; Gao CY; Li JC; Zhang LL
Gene; 2012 Dec; 511(1):12-7. PubMed ID: 22982410
[TBL] [Abstract][Full Text] [Related]
24. APOE genotypes and disease severity in multiple sclerosis.
Masterman T; Zhang Z; Hellgren D; Salter H; Anvret M; Lilius L; Lannfelt L; Hillert J
Mult Scler; 2002 Apr; 8(2):98-103. PubMed ID: 11990879
[TBL] [Abstract][Full Text] [Related]
25. Association of apolipoprotein E and myeloperoxidase genotypes to clinical course of familial and sporadic multiple sclerosis.
Zakrzewska-Pniewska B; Styczynska M; Podlecka A; Samocka R; Peplonska B; Barcikowska M; Kwiecinski H
Mult Scler; 2004 Jun; 10(3):266-71. PubMed ID: 15222689
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E genotype does not influence the progression of multiple sclerosis.
Savettieri G; Andreoli V; Bonavita S; Cittadella R; Caltagirone C; Fazio MC; Girlanda P; Le Pira F; Liguori M; Logroscino G; Lugaresi A; Nocentini U; Reggio A; Salemi G; Serra P; Tedeschi G; Toma L; Trojano M; Valentino P; Quattrone A
J Neurol; 2003 Sep; 250(9):1094-8. PubMed ID: 14504972
[TBL] [Abstract][Full Text] [Related]
27. Influence of apolipoprotein E epsilon4 genotype on brain tissue integrity in relapsing-remitting multiple sclerosis.
De Stefano N; Bartolozzi ML; Nacmias B; Zipoli V; Mortilla M; Guidi L; Siracusa G; Sorbi S; Federico A; Amato MP
Arch Neurol; 2004 Apr; 61(4):536-40. PubMed ID: 15096402
[TBL] [Abstract][Full Text] [Related]
28. Apo E in multiple sclerosis and optic neuritis: the apo E-epsilon4 allele is associated with progression of multiple sclerosis.
Pinholt M; Frederiksen JL; Andersen PS; Christiansen M
Mult Scler; 2005 Oct; 11(5):511-5. PubMed ID: 16193886
[TBL] [Abstract][Full Text] [Related]
29. ApoE epsilon4 allele and disease duration affect verbal learning in mild temporal lobe epilepsy.
Gambardella A; Aguglia U; Chifari R; Labate A; Manna I; Serra P; Romeo N; Sibilia G; Lepiane E; Russa AL; Ventura P; Cittadella R; Sasanelli F; Colosimo E; Leggio U; Zappia M; Quattrone A
Epilepsia; 2005 Jan; 46(1):110-7. PubMed ID: 15660776
[TBL] [Abstract][Full Text] [Related]
30. Polymorphisms of apolipoprotein E; outcome and susceptibility in multiple sclerosis.
Weatherby SJ; Mann CL; Davies MB; Carthy D; Fryer AA; Boggild MD; Young C; Strange RC; Ollier W; Hawkins CP
Mult Scler; 2000 Feb; 6(1):32-6. PubMed ID: 10694843
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein E ε4 does not affect cognitive performance in patients with Parkinson's disease.
Mengel D; Dams J; Ziemek J; Becker J; Balzer-Geldsetzer M; Hilker R; Baudrexel S; Kalbe E; Schmidt N; Witt K; Liepelt-Scarfone I; Gräber S; Petrelli A; Neuser P; Schulte C; Linse K; Storch A; Wittchen HU; Riedel O; Mollenhauer B; Ebentheuer J; Trenkwalder C; Klockgether T; Spottke A; Wüllner U; Schulz JB; Reetz K; Heber IA; Ramirez A; Dodel R
Parkinsonism Relat Disord; 2016 Aug; 29():112-6. PubMed ID: 27321987
[TBL] [Abstract][Full Text] [Related]
32. APOE ε4 Genotype and the Risk for Subjective Cognitive Impairment in Elderly Persons.
Krell-Roesch J; Woodruff BK; Acosta JI; Locke DE; Hentz JG; Stonnington CM; Stokin GB; Nagle C; Michel BF; Sambuchi N; Caselli RJ; Geda YE
J Neuropsychiatry Clin Neurosci; 2015; 27(4):322-5. PubMed ID: 25803305
[TBL] [Abstract][Full Text] [Related]
33. APOE epsilon4 is associated with impaired verbal learning in patients with MS.
Koutsis G; Panas M; Giogkaraki E; Potagas C; Karadima G; Sfagos C; Vassilopoulos D
Neurology; 2007 Feb; 68(8):546-9. PubMed ID: 17310023
[TBL] [Abstract][Full Text] [Related]
34. Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: retrospective and prospective analysis.
Kleiman T; Zdanys K; Black B; Rightmer T; Grey M; Garman K; Macavoy M; Gelernter J; van Dyck C
Dement Geriatr Cogn Disord; 2006; 22(1):73-82. PubMed ID: 16699282
[TBL] [Abstract][Full Text] [Related]
35. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
[TBL] [Abstract][Full Text] [Related]
36. The association between delirium and the apolipoprotein E epsilon4 allele in the elderly.
van Munster BC; Korevaar JC; de Rooij SE; Levi M; Zwinderman AH
Psychiatr Genet; 2007 Oct; 17(5):261-6. PubMed ID: 17728664
[TBL] [Abstract][Full Text] [Related]
37. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
[TBL] [Abstract][Full Text] [Related]
38. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
39. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
40. APOE epsilon variation in multiple sclerosis susceptibility and disease severity: some answers.
Burwick RM; Ramsay PP; Haines JL; Hauser SL; Oksenberg JR; Pericak-Vance MA; Schmidt S; Compston A; Sawcer S; Cittadella R; Savettieri G; Quattrone A; Polman CH; Uitdehaag BM; Zwemmer JN; Hawkins CP; Ollier WE; Weatherby S; Enzinger C; Fazekas F; Schmidt H; Schmidt R; Hillert J; Masterman T; Hogh P; Niino M; Kikuchi S; Maciel P; Santos M; Rio ME; Kwiecinski H; Zakrzewska-Pniewska B; Evangelou N; Palace J; Barcellos LF
Neurology; 2006 May; 66(9):1373-83. PubMed ID: 16682670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
